List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 30 studies with search of:   "Tipranavir"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours
Condition: HIV Infections
Intervention: Drug: tipranavir/ritonavir (dose reduction)
2 Completed Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
Condition: HIV Infections
Intervention: Drug: Buprenorphine, Tipranavir and ritonavir
3 Completed Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals
Condition: HIV Infections
Intervention: Drug: Protease inhibitor tipranavir
4 Available Emergency Use Program for HTE HIV+ Patients Who Need Tipranavir Treatment
Condition: HIV Infections
Interventions: Drug: Tipranavir Capsules;   Drug: Tipranavir Oral Solution
5 Completed Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
6 Completed Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)
Condition: HIV Infections
Intervention: Drug: Tipranavir (with low dose ritonavir)
7 Completed 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
Condition: HIV Infections
Intervention: Drug: Tipranavir
8 Active, not recruiting Pharmacokinetic (PK) Study of Single-Dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Ritonavir;   Drug: Rosuvastatin
9 Completed Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)
Condition: HIV Infections
Intervention: Drug: Tipranavir/Ritonavir
10 Completed Safety Study of Tipranavir Co-Administered With Low-Dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options
Condition: HIV Infections
Intervention: Drug: Tipranavir/Ritonavir
11 Completed Tipranavir/Ritonavir (TPV/r) in Protease Inhibitor (PI)-Experienced Patients With HIV-1 Infection
Condition: HIV Infection
Intervention: Drug: Tipranavir co-administered with low dose ritonavir
12 Terminated Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Darunavir;   Drug: Ritonavir
13 Recruiting Pharmaco-Epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy
Condition: HIV Infections
Intervention: Drug: tipranavir
14 Recruiting Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Efavirenz;   Drug: Indinavir/ritonavir;   Drug: Nelfinavir;   Drug: Saquinavir/ritonavir;   Drug: Lopinavir/ritonavir;   Drug: Atazanavir;   Drug: Atazanavir/ritonavir;   Drug: Fos-amprenavir/ritonavir;   Drug: Tipranavir/ ritonavir;   Drug: Darunavir/ritonavir
15 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study
Condition: HIV Infections
Interventions: Drug: lopinavir;   Drug: atazanavir;   Drug: efavirenz;   Drug: fosamprenavir;   Drug: darunavir;   Drug: tipranavir;   Drug: ritonavir;   Drug: nevirapine;   Drug: zidovudine;   Drug: lamivudine;   Drug: tenofovir;   Drug: emtricitabine;   Drug: abacavir
16 Terminated SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
17 Completed Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together
Condition: HIV Infection
Intervention: Drug: apricitabine
18 Terminated Safety and Antiviral Activity of TPV in HCV and/or HBV HIV co-Infected Patients TDM Randomized Pilto Evaluation
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
19 Completed Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir;   Drug: saquinavir;   Drug: amprenavir;   Drug: lopinavir
20 Recruiting Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents
Condition: HIV Infections
Interventions: Drug: Nelfinavir;   Drug: Lopinavir/ritonavir;   Drug: Ritonavir;   Drug: Amprenavir;   Drug: Indinavir;   Drug: Saquinavir;   Drug: Fosamprenavir;   Drug: Atazanavir;   Drug: Tipranavir

Previous Page Studies Shown (1-20) Next (21-30)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services